Point-of-Care HbA1c in Clinical Practice: Caveats and Considerations for Optimal Use.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 38552140.
- Also identified by DOI 10.2337/dci23-0040 and PMC identifier 11208753.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hemoglobin A1c (A1C) is widely used for the diagnosis and management of diabetes. Accurate measurement of A1C is necessary for optimal clinical value. Assay standardization has markedly improved the accuracy and consistency of A1C testing. Devices to measure A1C at point of care (POC) are commercially available, allowing rapid results when the patient is seen. In this review, we describe how standardization of A1C testing was achieved, leading to high-quality results in clinical laboratories. We address the use of POC A1C testing in clinical situations and summarize the advantages and disadvantages of POC A1C testing. We emphasize the importance of considering the limitations of these devices and following correct testing procedures to ensure that accurate A1C results are obtained for optimal care of patients.
Medical subject headings
- Glycated Hemoglobin
- Point-of-Care Systems